title: Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system.
abstract: The purpose of the present investigation was to prepare matrix tablets of naproxen using a hydrophobic polymer, i.e., Eudragit RLPO, RSPO, and combination of both, by wet granulation method. The tablets were further coated with different concentrations of Eudragit S-100, a pH-sensitive polymer, by dip immerse method. In vitro drug release studies of tablets were carried out in different dissolution media, i.e., 0.1 N HCl (pH 1.2), phosphate buffers pH 6.8 and 7.4, with or without rat cecal content. The swelling studies of the optimized formulation were carried out. The physicochemical parameters of all the formulations were found to be in compliance with the pharmacopoeial standards. The effect of dissolution medium on the surface of matrix tablet was determined by using Scanning Electron Microscopy technique. The stability studies of all formulations were performed as per ICH guidelines. The results demonstrated that the tablets coated with Eudragit S-100 (2% w/v) showed a sustained release of 94.67% for 24 h, but drug release increased to about 98.60% for 24 h in the presence of rat cecal content while the uncoated tablets released the drug within 5 h. With regard to release kinetics, the data were best fitted with the Higuchi model with non-Fickian drug release kinetics mechanism. The stability studies of tablets showed less degradation during accelerated and room temperature storage conditions for 6 months. The enteric-coated Eudragit S-100 coated matrix tablets of naproxen showed promising site-specific drug delivery in the colon region.
authors: Department of Pharmaceutics, Chitkara College of Pharmacy, Chitkara University, Chandigarh-Patiala Highway, Rajpura, Patiala, Punjab, India.
authors: Rohit
authors: R
authors: Mehta
authors: Anuj
authors: A
authors: Chawla
authors: Pooja
authors: P
authors: Sharma
authors: Pravin
authors: P
authors: Pawar
keywords: Eudragit S-100; matrix tablets; naproxen; non-Fickian; rat cecal
references: J Drug Target. 2003 Jul;11(6):365-71
references: 14668057
references: J Drug Target. 1999;7(3):223-32
references: 10680978
references: Drug Dev Ind Pharm. 2003 Jul;29(6):661-7
references: 12889784
references: J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66
references: 12753729
references: Crit Rev Ther Drug Carrier Syst. 1995;12(2-3):101-49
references: 9501968
references: Drug Dev Ind Pharm. 2007 Mar;33(3):255-64
references: 17454058
references: Indian J Pharm Sci. 2011 Mar;73(2):208-15
references: 22303065
references: Drug Deliv. 2009 Feb;16(2):67-74
references: 19267297
references: Indian J Pharm Sci. 2008 Sep;70(5):596-602
references: 21394255
references: J Drug Target. 2008 Dec;16(10):741-57
references: 19005938
references: AAPS PharmSciTech. 2009;10(2):670-7
references: 19459052
references: Drug Dev Ind Pharm. 2000 May;26(5):549-54
references: 10789067
references: J Drug Target. 2004;12(9-10):607-12
references: 15621686
references: J Drug Target. 1994;2(3):241-57
references: 7812693
references: J Drug Target. 1998;6(2):129-49
references: 9886237
references: Eur J Pharm Sci. 2002 Aug;16(3):185-92
references: 12128173
references: J Drug Target. 1995;3(2):83-9
references: 7496731
references: Drug Deliv. 2009 May;16(4):205-13
references: 19514981
references: Int J Pharm. 2008 Feb 28;350(1-2):205-11
references: 17928177
references: Acta Pharm. 2007 Dec;57(4):479-89
references: 18165191
references: Drug Deliv. 2009 Aug;16(6):295-303
references: 19606943
references: Eur J Pharm Biopharm. 2007 Nov;67(3):707-14
references: 17540549
references: J Control Release. 1998 Feb 12;51(2-3):281-7
references: 9685926
references: J Control Release. 1999 Mar 29;58(2):215-22
references: 10053194
references: AAPS PharmSciTech. 2006 Jan 03;7(1):E1
references: 16584139
references: Drug Deliv. 2011 May;18(4):281-93
references: 21138335
references: Int J Pharm. 2002 Mar 20;235(1-2):1-15
references: 11879735
references: Drug Dev Ind Pharm. 2006 Jan;32(1):95-106
references: 16455608
references: J Drug Target. 2004 Feb;12(2):105-12
references: 15203904
references: Drug Deliv. 2011 Feb;18(2):122-30
references: 20954795
references: Pharm Dev Technol. 2013 Jul-Aug;18(4):906-15
references: 21797662